First-in-Class Vepdegestrant Approved in Advanced Breast Cancer

(MedPage Today) -- The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced on Friday. Approval of the first-in-class proteolysis targeting...
Source
MedPage Today
Opens original article in a new tab



